These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 10434230

  • 1. Lymphocyte suppression by rolipram with other immunosuppressive drugs.
    Briggs WA, Wu Q, Orgul O, Choi M, Scheel PJ, Burdick J.
    J Clin Pharmacol; 1999 Aug; 39(8):794-9. PubMed ID: 10434230
    [Abstract] [Full Text] [Related]

  • 2. Pentoxifylline potentiates in vitro lymphocyte suppression by glucocorticoids and immunosuppressive drugs.
    Briggs WA, Eustace J, Mathew S, Gimenez LF, Choi M, Scheel PJ, Burdick J.
    J Clin Pharmacol; 1998 Jun; 38(6):561-6. PubMed ID: 9650547
    [Abstract] [Full Text] [Related]

  • 3. Lymphocyte suppression by glucocorticoids with cyclosporine, tacrolimus, pentoxifylline, and mycophenolic acid.
    Briggs WA, Eustace J, Gimenez LF, Choi MJ, Scheel PJ, Burdick JF.
    J Clin Pharmacol; 1999 Feb; 39(2):125-30. PubMed ID: 11563403
    [Abstract] [Full Text] [Related]

  • 4. The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
    Liang L, Beshay E, Prud'homme GJ.
    Diabetes; 1998 Apr; 47(4):570-5. PubMed ID: 9568689
    [Abstract] [Full Text] [Related]

  • 5. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
    Navikas V, Matusevicius D, Söderström M, Pirskanen R, Fredrikson S, Link H.
    Clin Neuropharmacol; 1998 Apr; 21(4):236-44. PubMed ID: 9704165
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with chronic renal failure on hemodialysis treatment.
    Konno O, Hirano T, Katsuyama K, Oka K, Matsuno N, Nagao T.
    Transpl Immunol; 2007 Apr; 17(3):187-92. PubMed ID: 17331845
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication.
    Angel JB, Saget BM, Walsh SP, Greten TF, Dinarello CA, Skolnik PR, Endres S.
    AIDS; 1995 Oct; 9(10):1137-44. PubMed ID: 8519449
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pentoxifylline (PTX) selectively potentiates cyclosporine (CsA)-mediated suppression of cell-mediated lymphocytotoxicity. Median-effect analysis for the drug dose reductions in PTX and CsA combination treatment.
    Khabar KS, Dzimiri M, Parhar RS, Siddiqui S, Einspenner M, Al-Humaidan A, Al-Sediary ST.
    Transplantation; 1996 Mar 15; 61(5):838-41. PubMed ID: 8607194
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H, Strassmann G, Chan CC, Rizzo LV, Silver PB, Wiggert B, Caspi RR.
    Invest Ophthalmol Vis Sci; 1999 Apr 15; 40(5):942-50. PubMed ID: 10102291
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Suppression of tumor necrosis factor-alpha production by interleukin-10 is enhanced by cAMP-elevating agents.
    Siegmund B, Eigler A, Moeller J, Greten TF, Hartmann G, Endres S.
    Eur J Pharmacol; 1997 Feb 26; 321(2):231-9. PubMed ID: 9063693
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lymphocyte responsiveness to glucocorticoids, cyclosporine, or both.
    Briggs WA, Gao ZH, Gimenez LF, Scheel PJ, Choi MJ, Burdick JF.
    J Clin Pharmacol; 1996 Aug 26; 36(8):707-14. PubMed ID: 8877674
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.